It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
originally posted by: Serdgiam
a reply to: PhyllidaDavenport
The antiviral aspects and ionophore activity will definitely have their biggest impact if given early on. This will stand true for pretty much any antiviral in any application, due to their nature.
Whether the ionophore activity, specifically, has benefits in later progressions is still up in the air a bit.
However, a medication like HCQ also has immunosuppresant/modulating effects which can be extremely helpful in many presentations. I suspect there are other factors that come into play when cytokines start running rampant, but HCQ could help control it regardless. There are other medications that would likely be more effective in this role, but many dont have the benefits that come from the early treatment of HCQ either.
originally posted by: Serdgiam
a reply to: one4all
Im not convinced you are asking in good faith, but here ya go all the same.
We dont even necessarily disagree, but you are clearly on a Crusade. I wish you the best in it.
originally posted by: ManFromEurope
NO at Hydroxycholorquine, and you can't get a better study:
originally posted by: gortex
a reply to: OccamsRazor04
Obviously by that reasoning the clinicians who carried out the study are wrong , guy on the internet wins the day and saves humanity.
originally posted by: AutomateThis1
a reply to: one4all
As bad as a wrap wormwood has recieved since ancient times, I actually like it.
Not that bad. Never understood the whole hallucinating thing though.
It's also known that HCQ is zinc ionophore, so zinc can interrupt RNA replication and transcription when present within a cell but it very hard for it to get into and between cells without an ionophore to facilitate the transfer, which in this case is the forementioned HCQ (also quinine).
originally posted by: carewemust
a reply to: 727Sky
So far, it looks like only Hydroxychloroquine-based treatments continue to show promise.
Attached and posted here (cqhcqresearch) is a summary of peer-reviewed evidence, indexed in PubMed, concerning the use of CQ and HCQ against coronavirus. We believe that there is clear and convincing evidence of benefit both pre-exposure and post-exposure.
...
It is important to recognize that “COVID-19 pneumonia” does not cause ARDS. The initial phase of “oxygenation failure” is characterized by normal lung compliance, with poor recruitability and near normal lung water (as measured by transpulmonary thermodilution). This is the “L phenotype” as reported by Gattonini and colleagues. [57-60] Treating these patients with early intubation and the ARDNSnet treatment protocol will cause the disease you are trying to prevent i.e. ARDS. These patients tolerate hypoxia remarkable well, without an increase in blood lactate concentration nor a fall in central venous oxygen saturation. We therefore suggest the liberal us of HFNC, with frequent patient repositioning (proning) and the acceptance of “permissive hypoxemia”. However, this approach entails close patient observation.
Three core pathologic processes lead to multi-organ failure and death in COVID-19:
1)Hyper-inflammation (“Cytokine storm”) ...
2)Hyper-coagulability (increased clotting) ...
3)Severe Hypoxemia(low blood oxygen levels) ...
The above pathologies are not novel, although the combined severity in COVID-19 disease is considerable. Our long-standing and more recent experiences show consistently successful treatment if traditional therapeutic principles of early and aggressive intervention is achieved, before the onset of advanced organ failure. It is our collective opinion that the historically high levels of morbidity and mortality from COVID-19 is due to a single factor: the widespread and inappropriate reluctance amongst intensivists to employ anti-inflammatory and anticoagulant treatments, including corticosteroid therapy early in the course of a patient’s hospitalization [ and proper antiviral treatment in the form of HCQ + quality care as early as possible, before hospitalization when it's already too late or almost too late]. It is essential to recognize that it is not the virus that is killing the patient, rather it is the patient’s overactive immune system [or the health care system depending on how you look at it or what interests you more, or health care workers blindly following horrible protocols, as they already more or less admitted to in this section, but OK, they're focussing on this detail now]. The flames of the “cytokine fire” are out of control and need to be extinguished. Providing supportive care (with ventilators that themselves stoke the fire) and waiting for the cytokine fire to burn itself out simply does not work... this approach has FAILED and has led to the death of tens of thousands of patients. [indeed, and that's not the only protocol, policy, guideline or behaviour that has caused more deaths than needed if you do things right, and don't hide behind a false screen of feigning incompetence as an excuse, or some supposed inability to know all this stuff ahead of time, before causing more deaths. This would bring us to the subject of misplaced trust in authoritive figures in the sciences including bureaucrats and bureaucrat scientists such as the careerjunkies at the WHO, FDA, CDC and associated government-funded research centers and publishers, the swamp in the sciences; they're all coming out of the woodwork with their lack of scientific integriry and love of the philosophy of vagueness now btw, NEJM, the Lancet, PubMed, etc.]
The systematic failure of critical care systems to adopt corticosteroid therapy resulted from the published recommendations against corticosteroids use by the World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), and the American Thoracic Society (ATS) amongst others. A very recent publication by the Society of Critical Care Medicine and authored one of the members of the Front Line COVID-19 Critical Care (FLCCC) group (UM), identified the errors made by these organizations in their analyses of corticosteroid studies based on the findings of the SARS and H1N1 pandemics. Their erroneous recommendation to avoid corticosteroids in the treatment of COVID-19 has led to the development of myriad organ failures which have overwhelmed critical care systems across the world.
Our treatment protocol targeting these key pathologies has achieved near uniform success, if begun within 6 hours of a COVID19 patient presenting with shortness of breath or needing ≥4L/min of oxygen. If such early initiation of treatment could be systematically achieved, the need for mechanical ventilators and ICU beds will decrease dramatically.
...
Finally, it is important to acknowledge that there is no known therapeutic intervention that has unequivocally been proven to improve the outcome of COVID-19. [not really true, but whatever, the crucial point comes now, it's still no excuse to opt for "supportive care"] This, however, does not mean we should adopt a nihilist approach and limit treatment to “supportive care”. [more accurately described as "horrible care" or "murderous care"] Furthermore, it is likely that there will not be a single “magic bullet” to cure COVID-19. Rather, we should be using multiple drugs/interventions that have synergistic and overlapping biological effects that are safe, cheap and “readily” available. The impact of COVID-19 on middle- and low-income countries will be enormous; these countries will not be able to afford expensive designer molecules.
Figure 7. The consequences of “steroid” avoidance” [and ultimately HCQ+quality care-avoidance at an early stage of the disease before hospitalization]. CT scan after 23 days of “supportive care” demonstrating the late fibroproliferative (irreversible) phase of COVID-19 lung disease (Image kindly provide by Dr. Pierre Kory, from NYC).
originally posted by: carewemust
a reply to: 727Sky
So far, it looks like only Hydroxychloroquine-based treatments continue to show promise.
originally posted by: ManFromEurope
This was very much like the VA study - it was a look back study of hospitalized patients. You don't know if the very sick patients may have received this drug as a hail Mary type try.